Bausch + Lomb Corp (BLCO): Next-Year EPS Estimate 33.20%
As of 2026-06-04, Bausch + Lomb Corp (BLCO) has a next-year EPS growth estimate of 33.20%.
BLCO was first flagged by our screen on 2026-05-31, when analyst consensus for its next-year EPS growth was revised from 32.73% to 33.20%. Current-year growth is projected at 58.04%.
Current Snapshot
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
- EPS growth next year
- 33.20%
- EPS growth this year
- 58.04%
- EPS next quarter (est)
- $0.15
- Last price
- $15.35
EPS Revision History
| Date | EPS Next Y | EPS This Y | Next Q (est) | Price |
|---|---|---|---|---|
| 2026-06-04 | 33.20% | 58.04% | $0.15 | $15.35 |
| 2026-06-03 | 33.20% | 58.04% | $0.15 | $14.87 |
| 2026-06-02 | 33.20% | 58.04% | $0.15 | $14.98 |
| 2026-06-01 | 33.20% | 58.04% | $0.15 | $15.39 |
| 2026-05-31 | 33.20% | 58.04% | $0.15 | $15.65 |
| 2026-05-28 | 32.73% | 56.64% | $0.15 | $15.59 |
| 2026-05-27 | 32.73% | 56.64% | $0.15 | $15.72 |
| 2026-05-26 | 32.76% | 56.49% | $0.15 | $15.78 |
| 2026-05-25 | 32.76% | 56.49% | $0.15 | $15.92 |
| 2026-05-24 | 32.76% | 56.49% | $0.15 | $15.92 |
| 2026-05-21 | 32.76% | 56.49% | $0.15 | $16.15 |
| 2026-05-20 | 32.86% | 56.49% | $0.15 | $16.20 |
| 2026-05-19 | 32.86% | 56.49% | $0.15 | $16.20 |
| 2026-05-18 | 32.59% | 56.49% | $0.15 | $16.11 |
| 2026-05-17 | 32.59% | 56.49% | $0.15 | $16.09 |
| 2026-05-14 | 32.59% | 56.49% | $0.15 | $16.27 |
| 2026-05-13 | 32.59% | 56.49% | $0.15 | $16.19 |
| 2026-05-12 | 32.59% | 56.49% | $0.15 | $16.03 |
| 2026-05-11 | 32.59% | 56.49% | $0.15 | $16.03 |
| 2026-05-10 | 32.59% | 56.49% | $0.15 | $16.18 |
| 2026-05-07 | 32.67% | 56.43% | $0.15 | $15.91 |
| 2026-05-06 | 32.67% | 56.43% | $0.15 | $16.00 |
| 2026-05-05 | 33.17% | 55.84% | $0.15 | $16.00 |
| 2026-05-04 | 33.43% | 55.84% | $0.15 | $16.30 |
| 2026-05-03 | 34.83% | 55.48% | $0.15 | $16.31 |
| 2026-04-30 | 34.83% | 55.48% | $0.15 | $15.90 |
| 2026-04-29 | 35.94% | 51.47% | $0.15 | $15.34 |
| 2026-04-28 | 36.61% | 52.06% | $0.05 | $15.72 |
| 2026-04-27 | 36.61% | 52.06% | $0.05 | $15.88 |
| 2026-04-26 | 36.66% | 52.02% | $0.05 | $15.82 |
Recent News
Screen Performance
Aggregate stats across all 1761 tickers our top-EPS-revision screen has flagged over the past 64 days.
- Median return since detection
- +5.1%
- % of tickers in the green
- 62%
- Median return on winners
- +17.5%
- Large revisions captured
- 746
Past detection performance reflects the price change between when a ticker first entered our screen and the most recent observation. Not a forward-looking forecast.
Frequently Asked Questions
What is Bausch + Lomb Corp's next-year EPS growth estimate?▾
As of 2026-06-04, Bausch + Lomb Corp (BLCO) has a next-year EPS growth estimate of 33.20%, based on analyst consensus.
When was the latest EPS estimate revision for BLCO?▾
The most recent revision occurred on 2026-05-31, when analysts adjusted the next-year EPS growth estimate from 32.73% to 33.20%.
What sector and industry does Bausch + Lomb Corp belong to?▾
Bausch + Lomb Corp operates in the Healthcare sector, specifically the Medical Instruments & Supplies industry.
How often is this EPS estimate data updated?▾
EPS revision data is refreshed daily from analyst consensus estimates. BLCO appears on this page because it was flagged by our daily top-EPS-revision-performer screen.
EPS revision data sourced from analyst consensus estimates, refreshed daily. Bausch + Lomb Corp (BLCO) appears here because it was detected by our daily top-EPS-revision-performer screen.
← All reports